Novartis venture fund is considering investing in a startup, Genedata, and should take into account the analysis and evaluation of launch, and venture evaluation - an independent organization, a boutique that specializes in assessing high-growth start-ups. SPC uses inputs venture evaluation to determine how best to structure the next round of funding Genedata continually requires the reader to discuss and analyze prices, future financing needs, as well as an exit strategy for the fund. "Hide
by Benoit Leleux, Victoria Kemanian, Atul Pahwa, Katrin Siebenburger Source: IMD 9 pages. Publication Date: 12 September 2005. Prod. #: IMD252-PDF-ENG
Related Case Solutions & Analyses:
IFRS: Canadas Decision
Positioning the Tata Nano (B)
ENSR International
Liability Management at General Motors
Whose Money Is It Anyway? (A)
Insuring the Poor: Bajaj Allianz Microinsurance Initiatives in India
Facilitating Knowledge Transfer During SOX-Mandated Audit Partner Rotation
The KBC Buyback Fund: Beating the Market with Buybacks
Indiana Toll Road (B): Will Winner’s Curse Strike Again?
MCI Communications Corp.: Capital Structure Theory (B)
